- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Spencer promotes blood flow imaging device
Spencer Technologies of Seattle has filed a 510(k) with the FDA to market a new transcranial Doppler device: a noninvasive combination of hardware and software that helps clinicians image and track blood flow with ultrasound. The company is
Spencer Technologies of Seattle has filed a 510(k) with the FDA to market a new transcranial Doppler device: a noninvasive combination of hardware and software that helps clinicians image and track blood flow with ultrasound.
The company is developing five proprietary Doppler ultrasound products addressing the detection, prevention, and treatment of conditions leading to stroke, pulmonary embolism, deafness, and cranial hemorrhage. The transcranial Doppler technology is designed to help diagnose conditions that may lead to stroke, according to the firm.
Spencer Technologies president and CEO Scott Seidel said customers will replace older analog ultrasound technology with this product.
Some ultrasound systems use harmonic imaging to visualize blood activity. The difference between transcranial Doppler and harmonic imaging is that the former images blood flow, while the latter visualizes the outline of blood vessels, Seidel said.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
